Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-concept trial in patients with drug-resistant focal onset seizures in epilepsy or focal epilepsy, as well as in phase 1 trial to treat acute anxiety. The company's products also comprise Tavapadon, a selective dopamine D1/D5 partial agonist that is in phase 3 clinical trial for the treatment of early- and late-stage Parkinson's disease; CVL-871, a selective dopamine D1/D5 partial agonist, which is in Phase 2a clinical trial to treat dementia-related apathy; CVL-936, a selective dopamine D3-preferring antagonist, which is in Phase I clinical trial for the treatment of substance use disorder; CVL-354, a selective kappa-opioid receptor antagonist to treat major depressive disorder and substance use disorder; and CVL-047, selective PDE4 inhibitor for the treatment of major depressive disorder and substance use disorder. It is also involved in the development of an M4 agonist program for the treatment of psychosis and related indications; and an LRRK2 inhibitor program to address disease progression in Parkinson's. The company was founded in 2018 and is headquartered in Cambridge, Massachusetts. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Cerevel Therapeutics Holdings Inc..
Cerevel Therapeutics Holdings Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Cerevel Therapeutics Holdings Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Cerevel Therapeutics Holdings Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Cerevel Therapeutics Holdings Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Cerevel Therapeutics Holdings Inc. and all latest updates of the company are provided.
The 2025 version of Cerevel Therapeutics Holdings Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Cerevel Therapeutics Holdings Inc.- Key Facts
2.2 Cerevel Therapeutics Holdings Inc.- Geographic Locations
2.3 Cerevel Therapeutics Holdings Inc.- Subsidiaries and Affiliates
2.4 Cerevel Therapeutics Holdings Inc.- Business Divisions
2.5 Cerevel Therapeutics Holdings Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Cerevel Therapeutics Holdings Inc. Strategic Analysis Review
3.1 Cerevel Therapeutics Holdings Inc.- Key Strategies
3.2 Cerevel Therapeutics Holdings Inc.- Company Outlook Statement
3.3 Cerevel Therapeutics Holdings Inc.- SWOT Analysis
3.3.1 Cerevel Therapeutics Holdings Inc.- Key Strengths
3.3.2 Cerevel Therapeutics Holdings Inc.- Key Weaknesses
3.3.3 Cerevel Therapeutics Holdings Inc.- Potential Opportunities
3.3.4 Cerevel Therapeutics Holdings Inc.- Potential Threats
3.4 Cerevel Therapeutics Holdings Inc.- Key Competitors
4. Business Description of the Company
4.1 Cerevel Therapeutics Holdings Inc.- Business Overview
4.2 Cerevel Therapeutics Holdings Inc.- Operations by Segment
5 Products and Services Details
5.1 Cerevel Therapeutics Holdings Inc.- Key Products
5.2 Cerevel Therapeutics Holdings Inc.- Key Service Areas
5.3 Cerevel Therapeutics Holdings Inc.- Key Brands
6 Company Developments
6.1 Cerevel Therapeutics Holdings Inc.- Company History
6.2 Cerevel Therapeutics Holdings Inc.- Latest Developments
7 Financial Analysis
7.1 Cerevel Therapeutics Holdings Inc.- Income Statements
7.2 Cerevel Therapeutics Holdings Inc.- Balance Sheet
7.3 Cerevel Therapeutics Holdings Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Cerevel Therapeutics Holdings Inc.- Direct Competitors
8.2 Cerevel Therapeutics Holdings Inc.- Competitor Financial Ratios comparison
8.3 Cerevel Therapeutics Holdings Inc.- Competitor Stock Charts Comparison
8.4 Cerevel Therapeutics Holdings Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
Get Free Sample
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Why Request a Free Sample?
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
FAQ's
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!
Reach Out to Us
Industries
Resources
Company
Sign up for Offers & Promotions
- Connect with us
- +91 630 95 25755
- sales@swotreports.com
-
Chat on WhatsApp
